Related Experiment Videos
Pectin coated hollow fiber polypropylene membranes
D Lewińska1, W Piatkiewicz, S Rosiński
1Institute of Biocybernetics and Biomedical Engineering, Laboratory of Capillary Mass Exchangers, Warsaw, Poland.
The International Journal of Artificial Organs
|February 17, 1998
Summary
Researchers developed a pectin-coated polypropylene membrane for selective removal of low-density lipoprotein cholesterol (LDL-C). The composite membrane shows potential for extracorporeal blood purification applications.
Area of Science:
- Biomaterials Science
- Chemical Engineering
- Medical Device Development
Background:
- Cardiovascular disease remains a leading cause of mortality worldwide.
- Elevated levels of low-density lipoprotein cholesterol (LDL-C) are a primary risk factor for atherosclerosis.
- Current methods for LDL-C removal have limitations, necessitating novel approaches.
Purpose of the Study:
- To develop a composite membrane for selective extracorporeal removal of human LDL-cholesterol.
- To investigate pectin as an active adsorber for LDL-C.
- To evaluate different preparation methods for the composite membrane.
Main Methods:
- Pectin was coated onto porous polypropylene (PP) membranes.
- Three preparation techniques were explored: native PP coating, chemically etched PP coating, and gamma-irradiated coated PP.
- Scanning electron microscopy (SEM) was used to characterize the pectin layers.
- Hydraulic permeability was assessed to evaluate membrane performance.
Main Results:
- Pectin layers of varying thicknesses (2-16 micrometers) and porosity were successfully formed on native and etched PP membranes.
- Chemical etching enhanced the adhesion and structure of the pectin coating.
- Gamma irradiation did not yield insoluble pectin layers, indicating it's unsuitable for this application.
Conclusions:
- The pectin-coated polypropylene membrane (PCF) is a promising candidate for selective LDL-C removal.
- The preparation method significantly influences the properties of the composite membrane.
- Further research is warranted to optimize PCF for clinical extracorporeal applications.